Published in Cancer Res on September 01, 1978
Using cytochalasins to improve current chemotherapeutic approaches. Anticancer Agents Med Chem (2015) 0.83
Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models. Invest New Drugs (2015) 0.82
Chemotherapy in vivo against M109 murine lung carcinoma with cytochalasin B by localized, systemic, and liposomal administration. Invest New Drugs (2015) 0.79
Inhibition of DNA synthesis in adrenocortical cells by cytochalasin B. J Cell Biol (1980) 0.75
Effects of cytochalasin congeners, microtubule-directed agents, and doxorubicin alone or in combination against human ovarian carcinoma cell lines in vitro. BMC Cancer (2015) 0.75
Preparation, In Vivo Administration, Dose-Limiting Toxicities, and Antineoplastic Activity of Cytochalasin B. Transl Oncol (2015) 0.75
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (1992) 25.54
Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A (1995) 8.16
Role of simian virus 40 gene A function in maintenance of transformation. J Virol (1975) 6.63
Construction and characterization of an SV40 mutant defective in nuclear transport of T antigen. Cell (1984) 5.81
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet (1996) 4.36
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet (1993) 3.85
Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med (2001) 3.72
Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nat Genet (1994) 3.22
The effect of arabinofuranosylcytosine on the growth cycle of simian virus 40. Virology (1965) 2.98
The occurrence of diphosphoinositide and triphosphoinositide in Saccharomyces cerevisiae. J Biol Chem (1968) 2.75
In vitro studies of phospholipid biosynthesis in Saccharomyces cerevisiae. Biochim Biophys Acta (1972) 2.73
Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell (1992) 2.55
Seroconversion, sexual activity, and condom use among 2915 HIV seronegative men followed for up to 2 years. J Acquir Immune Defic Syndr (1989) 2.48
Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. Proc Natl Acad Sci U S A (1984) 2.44
Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev (1995) 2.41
DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med (1992) 2.28
SV40-adenovirus "hybrid" populations: transfer of SV40 determinants from one type of adenovirus to another. Proc Natl Acad Sci U S A (1965) 2.27
Sales of nonprescription cold remedies: a unique method of influenza surveillance. Pediatr Res (1979) 2.22
Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Nat Genet (1994) 2.19
Subcellular Localization of simian virus 40 large tumor antigen. J Virol (1979) 2.03
A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development. Oncogene (2000) 2.03
Over-expression of the EGF receptor is a hallmark of squamous cell carcinomas. J Pathol (1986) 2.02
Optimal conditions for uptake of exogenous DNA by Chinese hamster lung cells deficient in hypoxanthine-guanine phosphoribosyltransferase. Biochim Biophys Acta (1975) 1.95
Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol (1995) 1.95
A morphologically distinct candidate for an epithelial stem cell in mouse mammary gland. J Cell Sci (1988) 1.90
Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res (1999) 1.87
Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome. Am J Pathol (2000) 1.84
Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol (1990) 1.80
Interaction of a simian papovavirus and adenoviruses. I. Induction of adenovirus tumor antigen during abortive infection of simian cells. J Bacteriol (1966) 1.79
Association of a cellular heat shock protein with simian virus 40 large T antigen in transformed cells. J Virol (1989) 1.76
Oncogenicity and cell transformation by papovavirus SV40: the role of the viral genome. Adv Cancer Res (1972) 1.73
Controlled and functional expression of the Pseudomonas oleovorans alkane utilizing system in Pseudomonas putida and Escherichia coli. J Biol Chem (1987) 1.64
Hepatitis B virus X protein interferes with cellular DNA repair. J Virol (1998) 1.62
Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am J Hum Genet (1995) 1.62
Antigenic relationship of SV40 early proteins to purified large T polypeptide. Virology (1979) 1.61
Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene (1999) 1.60
PAK1 hyperactivation is sufficient for mammary gland tumor formation. Oncogene (2006) 1.57
Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog (1996) 1.56
The matrix attachment region-binding protein SATB1 participates in negative regulation of tissue-specific gene expression. Mol Cell Biol (1997) 1.50
Development of mammary preneoplasias in vivo from mouse mammary epithelial cell lines in vitro. Cancer Res (1992) 1.49
Distinction between the preneoplastic and neoplastic state of murine mammary glands. Proc Natl Acad Sci U S A (1972) 1.47
Psychological impact of receiving negative BRCA1 mutation test results in Ashkenazim. Genet Med (2001) 1.43
Transcription of mouse mammary tumor virus: identification of a candidate mRNA for the long terminal repeat gene product. J Virol (1983) 1.43
[Septic shock (I). Physiopathology, monitoring]. Med Clin (Barc) (1993) 1.41
The influence of host and tissue age on life span and growth rate of serially transplanted mouse mammary gland. Exp Gerontol (1971) 1.41
Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium. Mol Biol Cell (2001) 1.40
West Nile Virus in the New World: trends in the spread and proliferation of West Nile Virus in the Western Hemisphere. Zoonoses Public Health (2009) 1.39
Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology (1995) 1.37
A massive, cooling-flow-induced starburst in the core of a luminous cluster of galaxies. Nature (2012) 1.36
Phylogenetic and structural analyses of MMTV LTR ORF sequences of exogenous and endogenous origins. Virology (1993) 1.36
p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis. Proc Natl Acad Sci U S A (2001) 1.35
B and T cells are required for mouse mammary tumor virus spread within the mammary gland. J Immunol (1998) 1.33
Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res (1994) 1.31
Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats. Carcinogenesis (1998) 1.31
Differential ability of a T-antigen transport-defective mutant of simian virus 40 to transform primary and established rodent cells. Mol Cell Biol (1985) 1.30
Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease. J Virol (1998) 1.30
Purification and translation of murine mammary tumor virus mRNA's. J Virol (1981) 1.29
Forensic entomology: applications and limitations. Forensic Sci Med Pathol (2011) 1.29
Variation in properties of plaque progeny of PARA (defective simian papovavirus 40)-adenovirus 7. J Virol (1969) 1.28
Preferential growth of mammary tumors in intact mammary fatpads. Cancer Res (1981) 1.27
The retinoblastoma protein-binding region of simian virus 40 large T antigen alters cell cycle regulation in lenses of transgenic mice. Mol Cell Biol (1994) 1.27
Papovaviridae. Intervirology (1974) 1.26
The influence of mammogenic hormones on serially transplanted mouse mammary gland. Exp Gerontol (1971) 1.26
Antigenic and immunogenic characteristics of nuclear and membrane-associated simian virus 40 tumor antigen. J Virol (1980) 1.26
Progesterone, in addition to estrogen, induces cyclin D1 expression in the murine mammary epithelial cell, in vivo. Endocrinology (1997) 1.26
Negative regulation in correct tissue-specific expression of mouse mammary tumor virus in transgenic mice. Mol Cell Biol (1990) 1.23
p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res (1992) 1.23
Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Res (2001) 1.22
Measles revaccination. Persistence and degree of antibody titer by type of immune response. Am J Dis Child (1978) 1.22
Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res (1991) 1.22
A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation. Cancer Res (2001) 1.21
Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia. Science (1977) 1.21
The plasma-membrane-associated form of SV40 large tumor antigen: biochemical and biological properties. Biochim Biophys Acta (1986) 1.21
Replication in simian cells of defective viruses in an SV40-adenovirus "hybrid" population. J Bacteriol (1966) 1.21
Changes in the concentration of activation factor for phosphofructokinase in hepatocytes in response to glucose and glucagon. Biochem Biophys Res Commun (1980) 1.21
Differential phosphorylation of cytoplasmic and nuclear variants of simian virus 40 large T antigen encoded by simian virus 40-adenovirus 7 hybrid viruses. J Virol (1984) 1.21
Variants of defective simian papovavirus 40 (PARA) characterized by cytoplasmic localization of simian papovavirus 40 tumor antigen. J Virol (1969) 1.21
Fructose-2,6-P2, chemistry and biological function. Mol Cell Biochem (1982) 1.20
The mammary fat pad. J Mammary Gland Biol Neoplasia (1998) 1.19
Regulation of phosphatidylcholine biosynthesis by the methylation pathway in Saccharomyces cerevisiae. J Biol Chem (1969) 1.19
The interaction of phosphofructokinase with erythrocyte membranes. J Biol Chem (1979) 1.18
Modification of simian virus 40 large tumor antigen by glycosylation. Virology (1985) 1.18
Demonstration of infectious deoxyribonucleic acid in transformed cells. I. Recovery of simian virus 40 from yielder and nonyielder transformed cells. J Virol (1972) 1.18
Intracellular transport of SV40 large tumor antigen: a mutation which abolishes migration to the nucleus does not prevent association with the cell surface. Virology (1982) 1.17
Discrete high molecular weight RNA transcribed from the long interspersed repetitive element L1Md. Nucleic Acids Res (1987) 1.17
Mitogenic effects of the proto-oncogene and oncogene forms of c-H-ras DNA in human diploid fibroblasts. Mol Cell Biol (1986) 1.17
Serological evidence of SV40 infections in HIV-infected and HIV-negative adults. J Med Virol (1998) 1.17
Expression of pregnancy-specific genes in preneoplastic mouse mammary tissues from virgin mice. Cancer Res (1984) 1.17
Studies with human papilloma virus modeled after known papovavirus systems. J Natl Cancer Inst (1972) 1.17
Heterozygosity of p21WAF1/CIP1 enhances tumor cell proliferation and cyclin D1-associated kinase activity in a murine mammary cancer model. Cell Growth Differ (1999) 1.16
Tumor suppressor p53 mutations and breast cancer: a critical analysis. Adv Cancer Res (1995) 1.16
Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis. Oncogene (1998) 1.16